The economics of improving global infectious disease surveillance

Linda de Vries, Marion Koopmans, Alec Morton, Pieter van Baal

Research output: Contribution to journalArticlepeer-review

Abstract

With the global increase in population density, urbanisation, and global travel and trade, the threat of widespread outbreaks of infectious diseases has increased relentlessly,1 as evidenced by recent examples of COVID-19 and Ebola. Further, although the most important causes of death shifted to non-communicable diseases, in some poorer parts of the world, communicable diseases remain the most important cause of death.2 Crucial in the prevention of and reaction to these threats is early detection, which demands an infectious disease surveillance system that can signal unusual events. How to set up and improve surveillance and how to prioritise investments are questions that need input from different scientific disciplines. Here, we focus on some economic considerations.
Original languageEnglish
Article numbere006597
Number of pages5
JournalBMJ Global Health
Volume6
Issue number9
DOIs
Publication statusPublished - 2 Sep 2021

Keywords

  • infectious diseases
  • disease surveillance
  • global surveillance

Fingerprint

Dive into the research topics of 'The economics of improving global infectious disease surveillance'. Together they form a unique fingerprint.

Cite this